Neurodevelopmental evaluation of 9‐month‐old infants exposed to low levels of lead in utero: involvement of monoamine neurotransmitters

The objective of this work is to investigate the neurotoxicty of low‐level lead exposure in utero on infants and the possible involvement of dopaminergic and serotonergic neurotransmitters. The correlation analysis for cord blood lead level, the concentrations of dopamine metabolite homovanillic acid (HVA) and serotonin metabolite 5‐hydroxyindoleacetic acid (5‐HIAA) in cord plasma and the neurodevelopmental scales of infants were conducted on 244 9‐month‐old children. Both score of sociability subscale and 5‐HIAA concentration were correlated with cord blood lead level. The sociability score was negatively correlated with the concentration of HVA, whereas both the coordination score and the global score were negatively correlated with the concentration of 5‐HIAA. With partial correlation analysis, after taking HVA into account, the significant negative correlation between the sociability score and the cord blood lead level that existed in the linear correlation analysis disappeared, and the score of global scale correlated negatively with lead level in cord blood. When taking 5‐HIAA into account, the scores of all the neurodevelopmental subscales except the language subscale were significantly negatively correlated with lead level in cord blood. The results indicated that low‐level lead exposure in utero could produce a neurotoxic effect on the developing serotonergic system in infants. The neurotoxicity of low‐level lead exposure in utero may affect the sociability of infants. Serotonergic activity was shown to have a potential effect on neurodevelopmental assessment. It may interfere with the association between low‐level lead exposure in utero and other neurodevelopmental performances of 9‐month‐old children. Copyright © 1999 John Wiley & Sons, Ltd.

[1]  U. Ewers,et al.  Results from the European multicenter study on lead neurotoxicity in children: implications for risk assessment. , 1990, Neurotoxicology and teratology.

[2]  M. Albert,et al.  Plasma Homovanillic Acid and Performance on Motor and Cognitive Tasks in Community-Dwelling Elderly: MacArthur Studies of Successful Aging , 1994, Neuropsychopharmacology.

[3]  G. Jennings,et al.  Regional homovanillic acid production in humans. , 1993, Life sciences.

[4]  E. Zrenner,et al.  Persistent decrease of the dopamine-synthesizing enzyme tyrosine hydroxylase in the rhesus monkey retina after chronic lead exposure. , 1997, Neurotoxicology.

[5]  E. Silbergeld.  Mechanisms of lead neurotoxicity, or looking beyond the lamppost , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  K. Davis,et al.  Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. , 1991, Archives of general psychiatry.

[7]  N. Fréry,et al.  Joint effect of gestational age and maternal lead exposure on psychomotor development of the child at six years. , 1992, Neurotoxicology.

[8]  I. Kopin.  Origins and Significance of Dopa and Catecholamine Metabolites in Body Fluids , 1992, Pharmacopsychiatry.

[9]  K. Davis,et al.  Homovanillic acid measurement in clinical research: a review of methodology. , 1992, Schizophrenia bulletin.

[10]  Decastro Fj.  Plasma catecholamine activity in chronic lead poisoning. , 1990 .

[11]  E. Marshall,et al.  Estimation of human blood plasma 5-hydroxyindoleacetic acid and homovanillic acid. , 1990, Biomedical chromatography : BMC.

[12]  H. Tang,et al.  Alterations of monoamine metabolites and neurobehavioral function in lead-exposed workers. , 1995, Biomedical and environmental sciences : BES.

[13]  A. L. Jadhav,et al.  Low Level Lead Exposure Decreases In Vivo Release of Dopamine in the Rat Nucleus Accumbens: A Microdialysis Study , 1995, Journal of neurochemistry.

[14]  Carolyn M. Mazure,et al.  Elevated plasma monoamine metabolites in eating disorders , 1994, Psychiatry Research.

[15]  R. Goyer.  Transplacental transport of lead. , 1990, Environmental health perspectives.

[16]  N. Inestrosa,et al.  Platelet of Alzheimer patients: Increased counts and subnormal uptake and accumulation of [14C]5-hydroxytryptamine , 1993, Neuroscience Letters.

[17]  S. Pocock,et al.  Environmental lead and children's intelligence: a systematic review of the epidemiological evidence , 1994, BMJ.

[18]  R. Bull,et al.  The effects of lead on the developing central nervous system of the rat. , 1983, Neurotoxicology.

[19]  M. Gilbertson,et al.  Memory and plasma HVA changes in schizophrenia: Are they episode markers? , 1994, Biological Psychiatry.

[20]  M. Demitrack,et al.  Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: Preliminary findings , 1992, Biological Psychiatry.

[21]  G. Jennings,et al.  Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity. , 1991, Life sciences.

[22]  D. Cory-Slechta.  Bridging human and experimental animal studies of lead neurotoxicity: moving beyond IQ. , 1995, Neurotoxicology and teratology.

[23]  Kala Sv,et al.  Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead. , 1995 .

[24]  R. Goyer.  Results of lead research: prenatal exposure and neurological consequences. , 1996, Environmental Health Perspectives.

[25]  D. Cory-Slechta,et al.  Functional alterations in dopamine systems assessed using drug discrimination procedures. , 1993, Neurotoxicology.

[26]  D. Cory-Slechta,et al.  The effects of lead exposure on learning in a multiple repeated acquisition and performance schedule. , 1993, Neurotoxicology.

[27]  T. Simons.  Cellular interactions between lead and calcium. , 1986, British medical bulletin.

[28]  Chi-kung Ho,et al.  Lymphocyte β2-Adrenergic Receptors and Plasma Catecholamine Levels in Lead-Exposed Workers , 1996 .

[29]  M. W. Sauerhoff,et al.  Hyperactivity and Brain Catecholamines in Lead-Exposed Developing Rats , 1973, Science.

[30]  J. Rossouw,et al.  Apparent central neurotransmitter receptor changes induced by low-level lead exposure during different developmental phases in the rat. , 1987, Toxicology and applied pharmacology.

[31]  J Schwartz,et al.  Low-level lead exposure and children's IQ: a meta-analysis and search for a threshold. , 1994, Environmental research.